Timber Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR TREATING PIGMENTATION DISORDERS

Abstract:

The present invention relates to local or topical compositions containing a therapeutically effective amount of a selective endothelin-A (ET-A) receptor antagonist or inhibitor, preferably sitaxentan (also known as sitaxsentan), and pharmaceutically acceptable salts thereof. The compositions are useful for treating a patient that has a pigmentation disorder or irregularity.